Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Technical Chemical & Products (TCPI) -- Ignore unavailable to you. Want to Upgrade?

To: go4it who wrote (41)	12/22/1997 8:13:00 PM
From: Brander	Respond to of 111

Chuck, TCPI specializes in developing, mft, and marketing point-of-care medical products. They already have products on the market, producing revenue, including their Health Check (TM) line, which is a comprehensive line of home health screening and monitoring products. This includes a urine test for UTI's, a urine test for glucose, a home cholesterol test, home pregnancy tests, and others. This link concerns the rollout: biz.yahoo.com Their current product line provides a foundation, but, the product that could make this a very pofitable investment is the noninvasive blood glucose system: biz.yahoo.com If this system hits the market ahead of their competition, this stock could shoot to $40 (no hype). As far as I can tell, TCPI is much closer to bringing their product to the market than anyone else. They are the only company that I know of that currently has a working system. As the above link indicates, they are starting clinical trials, which, we all hope, will lead to rapid FDA approval. Zach's rating is 1.5, a healthy buy. It ranks 36/108 in their industry (Med Products). Consensus earnings estimate for 1998 is 1.09, compared to -0.45 this year. There are only 10 million shares outstanding with a float of 5 million (I really like this fundamental). The president and CEO holds a very large position.